Jane Street’s ChemoCentryx, Inc. CCXI Stock Holding History

Jane Street’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-76,400	Closed	-$3.95M	–	10850
2022 Q3	$3.95M	Buy	76,400 +13,100	+21%	+$541K	﹤0.01%	2998
2022 Q2	$1.57M	Sell	63,300 -107,700	-63%	-$2.37M	﹤0.01%	4623
2022 Q1	$4.29M	Sell	171,000 -301,700	-64%	-$8.48M	﹤0.01%	3296
2021 Q4	$17.2M	Sell	472,700 -410,200	-46%	-$14.4M	0.01%	1324
2021 Q3	$15.1M	Buy	882,900 +601,000	+213%	+$9.36M	0.01%	1346
2021 Q2	$3.77M	Buy	281,900 +250,300	+792%	+$6.17M	﹤0.01%	3146
2021 Q1	$1.62M	Buy	31,600 +10,200	+48%	+$614K	﹤0.01%	4434
2020 Q4	$1.32M	Sell	21,400 -108,100	-83%	-$6.19M	﹤0.01%	4212
2020 Q3	$7.1M	Buy	129,500 +109,800	+557%	+$5.91M	﹤0.01%	1509
2020 Q2	$1.13M	Buy	19,700 +9,000	+84%	+$490K	﹤0.01%	3882
2020 Q1	$430K	Buy	10,700 +400	+4%	+$17K	﹤0.01%	3809
2019 Q4	$407K	Buy	+10,300	New	+$181K	﹤0.01%	3931

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jane Street's CCXI Position: Q4 2022 in Review

Jane Street sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 7,822 shares — an estimated $404K sold.

Jane Street first reported a position in CCXI in Q4 2013 and held it in 15 quarters. The position peaked at $4.21M in Q2 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Jane Street reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Jane Street sold 7,822 ChemoCentryx, Inc. shares in Q4 2022, an estimated $404K.
Jane Street first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 15 quarters.
Jane Street's ChemoCentryx, Inc. position peaked at $4.21M in Q2 2021.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.